Sat Kartar Life Limited

Sat Kartar Life Limited (SATKARTAR) is a micro-cap Healthcare company valued at ₹211 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Sat Kartar Life Limited last traded at ₹139, up 4.71% on the day.

Financial performance

The company's business is improving, with annual revenue rising 23.1% and net profit growing 71.0% year-over-year. The latest quarter saw revenue increase 20.7% and net profit jump 50.0% compared to the same quarter a year earlier, with net profit margin expanding 2.4 percentage points to 8.5%.

Valuation multiples

The stock trades at 12.8 times earnings, a discount to the Healthcare median of 32.0, 4.29 times book value.

Things to watch

The stock is 16.2% below its 52-week high, and the company's market cap is ₹290 crore, classifying it as a micro-cap. The distance from the 52-week high suggests a potential pullback, though the company remains profitable with a strong return on equity of 25.3%.

Where it stands

Sat Kartar Life Limited has delivered strong growth in both revenue and net profit over the past year and quarter, with a notable expansion in net profit margin. The stock is currently trading 16.2% below its 52-week high, but the company remains profitable with a healthy return on equity.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.